1079274-94-4 Usage
Uses
Used in Pharmaceutical Industry:
(S)-N-(1-(5-fluoropyrimidin-2-yl)ethyl)-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine is used as a potential pharmaceutical compound for its unique structure and potential biological activity. (S)-N-(1-(5-fluoropyrimidin-2-yl)ethyl)-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine's heterocyclic nature suggests it may have specific interactions with biological targets, making it a candidate for the development of new drugs.
Used in Research and Development:
In the field of research and development, (S)-N-(1-(5-fluoropyrimidin-2-yl)ethyl)-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine serves as a valuable compound for studying its interactions with various biological systems. Its complex structure and functional groups make it an interesting subject for exploring new mechanisms of action and potential therapeutic applications.
Used in Drug Design and Synthesis:
(S)-N-(1-(5-fluoropyrimidin-2-yl)ethyl)-3-(5-isopropoxy-1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine is used as a starting point or a structural component in drug design and synthesis. Its unique arrangement of functional groups and heterocyclic rings can be leveraged to create novel drug candidates with specific therapeutic targets in mind.
Check Digit Verification of cas no
The CAS Registry Mumber 1079274-94-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,9,2,7 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1079274-94:
(9*1)+(8*0)+(7*7)+(6*9)+(5*2)+(4*7)+(3*4)+(2*9)+(1*4)=184
184 % 10 = 4
So 1079274-94-4 is a valid CAS Registry Number.
1079274-94-4Relevant academic research and scientific papers
9- (PYRAZOL- 3 -YL) - 9H- PURINE-2 -AMINE AND 3- (PYRAZ0L-3-YL) -3H-IMIDAZ0 [4, 5-B] PYRIDIN-5-AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
-
, (2009/01/20)
The present invention relates to compounds of Formula (I): and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.
